EcoDrugPlus

Ensembl ID : ENSDNOG00000036075
Gene Symbol: -
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSDNOG00000035908
Gene Symbol: -
1 Cross references
505 Possible Orthologues:

Ensembl ID : ENSDNOG00000037027
Gene Symbol: -
1 Cross references
234 Possible Orthologues:

Ensembl ID : ENSDNOG00000043968
Gene Symbol: -
1 Cross references
217 Possible Orthologues:

Ensembl ID : ENSDNOG00000036673
Gene Symbol: -
1 Cross references
285 Possible Orthologues:

Ensembl ID : ENSDNOG00000034753
Gene Symbol: -
1 Cross references
238 Possible Orthologues:

Ensembl ID : ENSDNOG00000034059
Gene Symbol: -
1 Cross references
505 Possible Orthologues:

Ensembl ID : ENSDNOG00000033783
Gene Symbol: -
1 Cross references
186 Possible Orthologues:

Ensembl ID : ENSDNOG00000043882
Gene Symbol: -
1 Cross references
139 Possible Orthologues:

Ensembl ID : ENSDNOG00000044004
Gene Symbol: -
1 Cross references
252 Possible Orthologues:

Ensembl ID : ENSDNOG00000033907
Gene Symbol: -
1 Cross references
334 Possible Orthologues:

Ensembl ID : ENSDNOG00000033543
Gene Symbol: -
1 Cross references
157 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).